Clyde & Co today announces the appointment of Jeff Cottle as Head of Regulatory & Investigations, White-Collar Crime and Sanctions, Americas, and Co-Head of White-Collar Crime and Sanctions, EMEA, marking the launch of a dedicated Regulatory & Investigations (R&I) capability in the Americas. Jeff, who joins the firm from Eversheds Sutherland – where he was Co-Head of the National Security Practice and Global Co-Head of the Industrials Sector – will be based in Clyde & Co’s Washington, D.C. office and will work closely with its global network of offices.

More >>

WilmerHale is pleased to announce that George O’Brien, a nationally recognized Food and Drug Administration (FDA) and life sciences regulatory lawyer, has joined the firm as a partner in its Regulatory and Government Affairs Department. He will be based in the firm’s Washington DC office and also work alongside the firm’s Corporate Group. Before WilmerHale, O’Brien spent nearly two decades in private practice at two international law firms.  Immediately prior to joining the firm, O’Brien served as Partner at Mayer Brown.

More >>

Corporate transactions attorney Michelle Rae Heisner has joined Baker Donelson as a shareholder in the Firm’s Washington, D.C. office, strengthening the national law firm’s complex mergers and acquisitions, strategic transactions, and board-level advisory capabilities. Prior to joining Baker Donelson, Ms. Heisner practiced at Baker McKenzie and Sullivan & Cromwell in New York, Washington, D.C., and Australia.

More >>

Alston & Bird has tapped former Food and Drug Administration (FDA) deputy chief counsel Perham Gorji to join its FDA: Compliance & Enforcement Team and Drug & Device practice, as a partner in Washington, D.C., strengthening the firm’s ability to handle enforcement matters, internal investigations, and regulatory disputes involving FDA-regulated medical products. Gorji arrives at the firm from DLA Piper.

More >>